• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    New insider Halbert Jon claimed ownership of 116,129 shares (SEC Form 3)

    6/17/25 9:30:09 PM ET
    $CAI
    Medical Specialities
    Health Care
    Get the next $CAI alert in real time by email
    SEC FORM 3 SEC Form 3
    FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0104
    Estimated average burden
    hours per response: 0.5
    1. Name and Address of Reporting Person*
    HALBERT JON

    (Last) (First) (Middle)
    C/O CARIS LIFE SCIENCES, INC.
    750 W. JOHN CARPENTER FREEWAY, SUITE 800

    (Street)
    IRVING TX 75039

    (City) (State) (Zip)
    2. Date of Event Requiring Statement (Month/Day/Year)
    06/17/2025
    3. Issuer Name and Ticker or Trading Symbol
    Caris Life Sciences, Inc. [ CAI ]
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Common Stock 116,129(1) D
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date Exercisable Expiration Date Title Amount or Number of Shares
    Series A Preferred Stock (2) (2) Common Stock 1,250,000 $0 I By Ke'Ohana Ventures, LLC(3)
    Explanation of Responses:
    1. Includes 16,129 shares of Common Stock underlying restricted stock units which vest in accordance with the applicable grant agreement.
    2. Each share of preferred stock is convertible at the holder's option into 0.25 shares of Common Stock of the Issuer, subject to adjustment in accordance with the certificate of formation, and will automatically convert upon the closing of the initial public offering of the Issuer's Common Stock.
    3. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.
    Remarks:
    Exhibit 24 - Power of Attorney.
    /s/ J. Russel Denton, Attorney-in-Fact 06/17/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $CAI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CAI

    DatePrice TargetRatingAnalyst
    6/30/2021$56.00Outperform → Mkt Perform
    Keefe Bruyette
    More analyst ratings

    $CAI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President Spetzler David Baxley returned $13,029,467 worth of shares to the company (700,509 units at $18.60), was granted 132,428 shares, exercised 75,000 shares at a strike of $2.44 and covered exercise/tax liability with 34,782 shares, decreasing direct ownership by 50% to 523,886 units (SEC Form 4)

      4 - Caris Life Sciences, Inc. (0002019410) (Issuer)

      6/23/25 6:41:24 PM ET
      $CAI
      Medical Specialities
      Health Care
    • Officer Power Luke Thomas was granted 99,321 shares, increasing direct ownership by 39,728% to 99,571 units (SEC Form 4)

      4 - Caris Life Sciences, Inc. (0002019410) (Issuer)

      6/23/25 6:40:16 PM ET
      $CAI
      Medical Specialities
      Health Care
    • Director Halbert Jon was granted 16,129 shares and converted options into 1,250,000 shares, increasing direct ownership by 16% to 116,129 units (SEC Form 4)

      4 - Caris Life Sciences, Inc. (0002019410) (Issuer)

      6/23/25 6:38:00 PM ET
      $CAI
      Medical Specialities
      Health Care